Redefining antibody cross-reactivity as an advantage for sensing and diagnostics
Trends in Biotechnology · 2025
DOI: 10.1016/j.tibtech.2025.05.017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2025. Verfasst von Josselyn Mata Calidonio und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering, School for the Environment, University of Massachusetts Boston, Boston, MA, USA. Hauptthemen laut MEDLINE: Antibodies, Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: University of Massachusetts Boston.
Abstract (Originalsprache)
Cross-reactivity is viewed as a highly undesirable property of antibodies, with efforts focused on achieving high specificity and minimal crosstalk. Yet, in selective arrays, cross-reactivity can be a strength. The ability to bind to a range of antigens can be powerful if used strategically to distinguish complex samples. Chemometric and chemolfactory arrays rely on cross-reactivity to deliver powerful assays with capabilities that often outperform those of specific assays. Here, we argue that there is a unique opportunity to exploit the cross-reactivity of antibodies by using them in array similar to the mode of chemolfactory arrays. Embracing this shift could transform biosensing, offering scalable tools for multiplexed detection, especially in settings where speed, cost, and adaptability are critical.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Engineering, School for the Environment, University of Massachusetts Boston, Boston, MA, USA.
- Department of Engineering, School for the Environment, University of Massachusetts Boston, Boston, MA, USA. Electronic address: kim.hamad@umb.edu.
Förderung
- University of Massachusetts Boston
Zitieren
APA
Mata Calidonio, J., & Hamad-Schifferli, K. (2025). Redefining antibody cross-reactivity as an advantage for sensing and diagnostics. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2025.05.017
Vancouver
Mata Calidonio J, Hamad-Schifferli K. Redefining antibody cross-reactivity as an advantage for sensing and diagnostics. Trends in Biotechnology. 2025. doi:10.1016/j.tibtech.2025.05.017
BibTeX
@article{MataCalidonio2025,
author = {Mata Calidonio, Josselyn and Hamad-Schifferli, Kimberly},
title = {Redefining antibody cross-reactivity as an advantage for sensing and diagnostics},
journal = {Trends in Biotechnology},
year = {2025},
doi = {10.1016/j.tibtech.2025.05.017}
}
EUVIMED